Stories of Sekkei
Welcome to Sekkei Bio
Welcome to Sekkei Bio
Sekkei Bio at
Spinco Biotech
Our founder Dr. Monalisa Chatterji, Dr. Anand Khedkar along with eminent RNA biologist Srivatsa Dwarakanath of the Max Planck Institute gave a talk through webinar conducted by Spinco Biotech:
Sekkei Bio among Top 10 Drug Research Companies 2023
India Pharma Outlook has featured Sekkei Bio one of the top 10 Drug Discovery & Development Companies in India in 2023.
Sekkei at Bio International Convention, July 13 -16, 2022
Dr. Anand Khedkar, one our co-founders participated at the prestigious Bio International Convention in San Diego, USA.
COVID Moonshot: A Collaborative Approach to Antiviral Discovery
Our co-founder Dr. Monalisa Chatterji along with Ed Griffen of MedChemica Ltd and Annette von Delft from University of Oxford, moderated a webinar on the COVID Moonshot consortium
Taking Novel Drugs from Lab to Clinic,7-11 March 2022
DNDi, the Indian Society for Clinical Research (ISCR), and BIRAC Regional Bio-Innovation Centre (a joint initiative of BIRAC and Venture Center) hosted a five day virtual workshop titled ‘Taking Novel Drugs from Lab to Clinic: Concepts and case Studies‘.
Session was chaired by our founder Dr. Monalisa Chatterji.
She Is: 75 Women in STEAM
One of our founders Monalisa Chatterji was honoured as one among 75 Indian woman in STEAM (fields of Science, Technology, Engineering, Arts and Mathematics) on the occasion of India’s 75th Independence Day commemorations by the Office of the Principal Scientific Advisor to the Government of India in partnership with Red Dot Foundation, British High Commission, and FICCI FLO.
Sekkei Bio incubated and mentored at C-CAMP
C-CAMP has emerged as a thriving hub for innovation with a vibrant ecosystem. We have interacted with over 500 inventors and entrepreneurs and encouraged them to translate their inventions into innovation. Till date C-CAMP has supported over 100 start-ups/spin-offs through funding, bio-incubation and mentorship.
Sekkei Bio in the News
Our co-founder Anand Khedkar spoke to The Economic Times on the emergence of a research and development ecosystem, along with early stage funding, being one of the reasons behind the birth of several deep-science companies and how it has helped Sekkei Bio in our research as well.
Sekkei Bio at Bengaluru Tech Summit 2020
Our co-founder Anirudh Ranganathan participated as a session panelist and delivered a talk at Bengaluru Tech Summit-2020 (BTS-2020)